Dr. Lifton estimated that the new method could apply to 10 to 15 percent of patients with Duchenne muscular dystrophy or cystic fibrosis. Dr. Liu’s team also reported estimates for a couple of other diseases, saying the method might help 252,000 people with Stargardt disease and 31,000 people with phenylketo
Continue Reading on New York Times
This preview shows approximately 15% of the article. Read the full story on the publisher's website to support quality journalism.